Search Results - "Whitcomb, Bradford P"

Frequent HOXA11 and THBS2 Promoter Methylation, and a Methylator Phenotype in Endometrial Adenocarcinoma by WHITCOMB, Bradford P, MUTCH, David G, HERZOG, Thomas J, RADER, Janet S, GIBB, Randall K, GOODFELLOW, Paul J

“…Purpose: This study was designed to determine whether there is a methylator phenotype in stage I and II endometrioid endometrial adenocarcinoma, and if so,…”
Get full text

Gynecologic Malignancies by Whitcomb, Bradford P., MD

“…The pioneers in the field of gynecologic oncology set out to establish an evidence-based approach to the care of women with gynecologic cancer, combining the…”
Get full text

ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Endometrial Cancer by Reinhold, Caroline, Ueno, Yoshiko, Akin, Esma A, Bhosale, Priyadarshani R, Dudiak, Kika M, Jhingran, Anuja, Kang, Stella K, Kilcoyne, Aoife, Lakhman, Yulia, Nicola, Refky, Pandharipande, Pari V, Paspulati, Rajmohan, Shinagare, Atul B, Small, Jr, William, Vargas, Hebert Alberto, Whitcomb, Bradford P, Glanc, Phyllis

“…To date, there is little consensus on the role of pelvic imaging in assessing local disease extent during initial staging in patients with endometrial…”
Get full text

ACR Appropriateness Criteria® Clinically Suspected Adnexal Mass, No Acute Symptoms by Atri, Mostafa, Alabousi, Abdullah, Reinhold, Caroline, Akin, Esma A., Benson, Carol B., Bhosale, Priyadarshani R., Kang, Stella K., Lakhman, Yulia, Nicola, Refky, Pandharipande, Pari V., Patel, Maitray D., Salazar, Gloria M., Shipp, Thomas D., Simpson, Lynn, Sussman, Betsy L., Uyeda, Jennifer W., Wall, Darci J., Whitcomb, Bradford P., Zelop, Carolyn M., Glanc, Phyllis

“…There are approximately 9.1 pelvic surgeries performed for every histologically confirmed adnexal malignancy in the United States, compared to 2.3 surgeries…”
Get full text

ACR Appropriateness Criteria® Staging and Follow-Up of Ovarian Cancer by Kang, Stella K., Reinhold, Caroline, Atri, Mostafa, Benson, Carol B., Bhosale, Priyadarshani R., Jhingran, Anuja, Lakhman, Yulia, Maturen, Katherine E., Nicola, Refky, Pandharipande, Pari V., Salazar, Gloria M., Shipp, Thomas D., Simpson, Lynn, Small, William, Sussman, Betsy L., Uyeda, Jennifer W., Wall, Darci J., Whitcomb, Bradford P., Zelop, Carolyn M., Glanc, Phyllis

“…In the management of epithelial ovarian cancers, imaging is used for cancer detection and staging, both before and after initial treatment. The decision of…”
Get full text

ACR Appropriateness Criteria® Placenta Accreta Spectrum Disorder by Poder, Liina, Weinstein, Stefanie, Maturen, Katherine E, Feldstein, Vickie A, Mackenzie, David C, Oliver, Edward R, Shipp, Thomas D, Strachowski, Loretta M, Sussman, Betsy L, Wang, Eileen Y, Weber, Therese M, Whitcomb, Bradford P, Glanc, Phyllis

“…Placenta accreta spectrum disorder (PASD) is the current terminology recommended by the International Federation of Obstetrics and Gynecology (FIGO) and should…”
Get full text

ACR Appropriateness Criteria® Gestational Trophoblastic Disease by Dudiak, Kika M., Maturen, Katherine E., Akin, Esma A., Bell, Maria, Bhosale, Priyadarshani R., Kang, Stella K., Kilcoyne, Aoife, Lakhman, Yulia, Nicola, Refky, Pandharipande, Pari V., Paspulati, Rajmohan, Reinhold, Caroline, Ricci, Stephanie, Shinagare, Atul B., Vargas, Hebert Alberto, Whitcomb, Bradford P., Glanc, Phyllis

“…Gestational trophoblastic disease (GTD), a rare complication of pregnancy, includes both benign and malignant forms, the latter collectively referred to as…”
Get full text

Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates by GIUS, David, FUNK, Margo C, COHN, David E, POWELL, Matthew A, HOROWITZ, Neil S, WHITCOMB, Bradford P, RADER, Janet S, CHUANG, Eric Y, SHENG FENG, HUETTNER, Phyllis C, NGUYEN, Loan, BRADBURY, C. Matthew, MISHRA, Mark, SHUPING GAO, BUTTIN, Barbara M

“…This study is the first comprehensive, integrated approach to examine grade-specific changes in gene expression along the entire neoplastic spectrum of…”
Get full text

Successful use of next generation genomic sequencing (NGS)-directed therapy of clear cell carcinoma of the ovary (CCCO) with trametinib and metformin in a patient with chemotherapy-refractory disease by Castro, Michael P, Whitcomb, Bradford P, Zajchowski, Deborah A, Coleman, Robert L

“…Compared to other subtypes of epithelial ovarian cancer, clear cell carcinoma of the ovary bears an ominous reputation for chemotherapy resistance, increased…”
Get full text

Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin by Lewin, Sharyn N., Mutch, David G., Whitcomb, Bradford P., Liapis, Helen, Herzog, Thomas J.

“…Hemolytic uremic syndrome (HUS) is a rare coagulation disorder characterized by microangiopathic hemolytic anemia, thrombocytopenia and acute uremia. Reports…”
Get full text

Primary Peritoneal Psammocarcinoma: A Case Presenting with an Upper Abdominal Mass and Elevated CA-125 by Whitcomb, Bradford P., Kost, Edward R., Hines, Jeffrey F., Zahn, Christopher M., Hall, Kevin L.

“…Primary peritoneal serous adenocarcinoma with predominating psammoma bodies, psammocarcinoma, is a very rare tumor with only seven cases documented in the…”
Get full text

Successful use of next generation genomic sequencing (NGS)-directed therapy of clear cell carcinoma of the ovary (CCCO) with trametinib and metformin in a patient with chemotherapy-refractory disease by Castro, Michael P, Whitcomb, Bradford P, Zajchowski, Deborah A, Coleman, Robert L

“…PURPOSECompared to other subtypes of epithelial ovarian cancer, clear cell carcinoma of the ovary bears an ominous reputation for chemotherapy resistance,…”
Get full text